Literature DB >> 25676034

Dramatic efficacy of low dose lenalidomide as single agent in a patient with refractory gastric non-human immunodeficiency virus-associated plasmablastic lymphoma.

Sylvain Carras1, Caroline Regny1, Michel Peoc'h2, Julie Gervasoni2, Remy Gressin1, Jean-Yves Cahn1, Lysiane Molina1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25676034     DOI： 10.3109/10428194.2015.1016931

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  5 in total

1.  A patient with plasmablastic lymphoma achieving long-term complete remission after thalidomide-dexamethasone induction and double autologous stem cell transplantation: a case report.

Authors:  Alessandro Broccoli; Laura Nanni; Vittorio Stefoni; Claudio Agostinelli; Lisa Argnani; Michele Cavo; Pier Luigi Zinzani
Journal:  BMC Cancer       Date:  2018-06-08       Impact factor: 4.430

2.  Allogeneic hematopoietic stem cell transplantation in a patient with HIV-negative recurrent plasmablastic lymphoma: A case report.

Authors:  Chunmeng Rong; Lixia Sheng; An Wu; Ye Sun; Guifang Ouyang
Journal:  Medicine (Baltimore)       Date:  2021-02-19       Impact factor: 1.817

3.  A True Mimicker to Plasmacytoma Clinically, Radiologically, and Pathologically - A Rare Case Report.

Authors:  Shino P Ashly; Anu C Thomas; Sajeev S Vadakkedam
Journal:  Asian J Neurosurg       Date:  2021-12-18

4.  Bortezomib, Lenalidomide and Dexamethasone Combination Induced Complete Remission in Relapsed/Refractory Plasmablastic Lymphoma: Case Report of a Potential Novel Treatment Approach.

Authors:  Waleed Sabry; Yue Wu; Shruthi Ganeshappa Kodad
Journal:  Curr Oncol       Date:  2022-07-18       Impact factor: 3.109

5.  Plasmablastic lymphoma masquerading solitary plasmacytoma in an immunocompetent patient.

Authors:  Rodrigo Diaz; Julan Amalaseelan; Louise Imlay-Gillespie
Journal:  BMJ Case Rep       Date:  2018-10-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.